WIA
CVS icon

Wealthstreet Investment Advisors’s CVS Health CVS Stock Holding History

Wealthstreet Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,124
Closed -$2.64M – 140
2021
Q1 		$2.64M Sell
35,124
-3,300
-9% -$240K 0.26% 92
2020
Q4 		$2.62M Sell
38,424
-500
-1% -$32.5K 0.27% 85
2020
Q3 		$2.27M Buy
38,924
+700
+2% +$43.6K 0.25% 93
2020
Q2 		$2.48M Buy
38,224
+1,700
+5% +$107K 0.3% 76
2020
Q1 		$2.17M Sell
36,524
-750
-2% -$50.1K 0.32% 75
2019
Q4 		$2.77M Sell
37,274
-1,987
-5% -$140K 0.32% 73
2019
Q3 		$2.59M Buy
39,261
+1,425
+4% +$84.4K 0.33% 70
2019
Q2 		$2.06M Buy
37,836
+736
+2% +$39.6K 0.27% 94
2019
Q1 		$2M Buy
37,100
+1,647
+5% +$102K 0.26% 92
2018
Q4 		$2.31M Buy
35,453
+554
+2% +$41.4K 0.32% 75
2018
Q3 		$2.75M Hold
34,899
– – 0.34% 71
2018
Q2 		$2.25M Sell
34,899
-150
-0.4% -$9.88K 0.3% 84
2018
Q1 		$2.18M Buy
35,049
+89
+0.3% +$6.39K 0.27% 90
2017
Q4 		$2.54M Buy
+34,960
New +$2.54M 0.31% 83

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealthstreet Investment Advisors's CVS Position: Q2 2021 in Review

Wealthstreet Investment Advisors sold out of CVS Health (CVS) in Q2 2021, closing a stake of 35,124 shares — an estimated $2.64M sold.

Wealthstreet Investment Advisors first reported a position in CVS in Q4 2017 and held it in 14 quarters. The position peaked at $2.77M in Q4 2019. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Wealthstreet Investment Advisors reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 35,124 CVS Health shares in Q2 2021, an estimated $2.64M.
  • Wealthstreet Investment Advisors first reported a position in CVS Health in Q4 2017 and held it in 14 quarters.
  • Wealthstreet Investment Advisors's CVS Health position peaked at $2.77M in Q4 2019.
  • 2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.